BPCE
Bank Pictet & Cie (Europe) Portfolio holdings
AUM
$4.68B
1-Year Return
16.47%
This Quarter Return
+12.27%
1 Year Return
+16.47%
3 Year Return
+101.24%
5 Year Return
+155.05%
10 Year Return
+381.72%
AUM
$2.41B
AUM Growth
+$360M
(+18%)
Cap. Flow
+$157M
Cap. Flow
% of AUM
6.53%
Top 10 Holdings %
Top 10 Hldgs %
42.18%
Holding
187
New
25
Increased
60
Reduced
55
Closed
15
Top Buys
| 1 |
Moderna
MRNA
|
+$30.4M |
| 2 |
Estee Lauder
EL
|
+$20.1M |
| 3 |
ATVI
Activision Blizzard Inc.
ATVI
|
+$18.1M |
| 4 |
Eli Lilly
LLY
|
+$17.3M |
| 5 |
PepsiCo
PEP
|
+$14.2M |
Top Sells
| 1 |
Vanguard Value ETF
VTV
|
+$13.2M |
| 2 |
UnitedHealth
UNH
|
+$10.7M |
| 3 |
3M
MMM
|
+$7.93M |
| 4 |
Chevron
CVX
|
+$7.44M |
| 5 |
iShares S&P 500 Value ETF
IVE
|
+$6.37M |
Sector Composition
| 1 | Healthcare | 24.97% |
| 2 | Technology | 17.74% |
| 3 | Consumer Discretionary | 13.04% |
| 4 | Communication Services | 10.58% |
| 5 | Financials | 10.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
151
Insulet
PODD
$24.1B
| $306K | 0.01% |
958
-564
| -37% | -$180K |
|
152
SPDR S&P Biotech ETF
XBI
$5.43B
| $293K | 0.01% |
3,850
-124
| -3% | -$9.45K |
|
153
Castle Biosciences
CSTL
$621M
| $289K | 0.01% |
12,740
+122
| +1% | +$2.77K |
|
154
Pure Storage
PSTG
$26.9B
| $278K | 0.01% |
10,882
+1,270
| +13% | +$32.4K |
|
|
CTLT
155
DELISTED
CATALENT, INC.
CTLT
| $275K | 0.01% |
+4,179
| New | +$275K |
|
156
DexCom
DXCM
$29.9B
| $273K | 0.01% |
2,353
-1,641
| -41% | -$191K |
|
157
Union Pacific
UNP
$127B
| $272K | 0.01% |
+1,350
| New | +$272K |
|
158
Deutsche Bank
DB
$71.6B
| $267K | 0.01% |
26,230
+9,830
| +60% | +$99.9K |
|
159
Tandem Diabetes Care
TNDM
$829M
| $259K | 0.01% |
+6,377
| New | +$259K |
|
160
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
$30.8B
| $251K | 0.01% |
2,291
| – | – |
|
161
iShares MSCI Japan ETF
EWJ
$15.7B
| $248K | 0.01% |
4,231
| – | – |
|
162
uniQure
QURE
$904M
| $248K | 0.01% |
12,301
+109
| +0.9% | +$2.2K |
|
163
UBS Group
UBS
$129B
| $246K | 0.01% |
11,666
| – | – |
|
164
DaVita
DVA
$9.52B
| $243K | 0.01% |
3,000
| – | – |
|
165
Arrowhead Research
ARWR
$4.11B
| $241K | 0.01% |
9,488
| – | – |
|
166
Iovance Biotherapeutics
IOVA
$821M
| $232K | 0.01% |
37,965
+9,879
| +35% | +$60.4K |
|
167
Morgan Stanley
MS
$250B
| $225K | 0.01% |
+2,557
| New | +$225K |
|
168
Blackstone
BX
$142B
| $211K | 0.01% |
+2,400
| New | +$211K |
|
169
iShares Russell 1000 Growth ETF
IWF
$120B
| $210K | 0.01% |
+860
| New | +$210K |
|
170
Rio Tinto
RIO
$101B
| $206K | 0.01% |
+3,000
| New | +$206K |
|
171
SPDR S&P MidCap 400 ETF Trust
MDY
$24B
| $201K | 0.01% |
+439
| New | +$201K |
|
172
Vodafone
VOD
$28.5B
| $181K | 0.01% |
16,420
| – | – |
|
173
Accenture
ACN
$149B
| – | – |
-1,149
| Closed | -$307K |
|
174
Baidu
BIDU
$39.5B
| – | – |
-8,829
| Closed | -$1.01M |
|
175
BioNTech
BNTX
$23.3B
| – | – |
-1,505
| Closed | -$226K |
|